Answer
Yes, cytokine release syndrome, including life-threatening or fatal events, has been frequently observed after Kymriah (tisagenlecleucel) infusion.
Sources for this answer
- Kymriah cells dispersion for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 15Document updated
Sources checked